Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/30/6a/6a/306a6a27-5590-6622-dfba-7d6a7d0dbbb0/mza_1420088730083196311.jpg/600x600bb.jpg
CannMed Coffee Talk
Medicinal Genomics
133 episodes
2 weeks ago
Brought to you by Medicinal Genomics & Advanced Nutrients
Show more...
Life Sciences
Health & Fitness,
Science,
Natural Sciences
RSS
All content for CannMed Coffee Talk is the property of Medicinal Genomics and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Brought to you by Medicinal Genomics & Advanced Nutrients
Show more...
Life Sciences
Health & Fitness,
Science,
Natural Sciences
https://cannmedevents.com/wp-content/uploads/2025/01/Coffee-Talk-Podcast-MICHELLEArtboard-1.jpg
Analyzing Unregulated Hemp-Derived Cannabinoid Products with Michelle Peace, PhD
CannMed Coffee Talk
49 minutes 11 seconds
10 months ago
Analyzing Unregulated Hemp-Derived Cannabinoid Products with Michelle Peace, PhD
Dr. Michelle Peace is an internationally recognized forensic toxicologist and a Full Professor in the Department of Forensic Science at Virginia Commonwealth University. The National Institute of Justice has funded her team to study the proliferation of semi-synthetic THC analogs in the unregulated market and define their relevant biomarkers. Her work impacts public health and public safety policies and initiatives.



At CannMed 25 Michelle will present “Why Some People “Green Out”? The Analysis of Unregulated “Hemp-derived” Cannabis Products”. Her team used a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to analyze unregulated hemp products. All the products they analyzed were mislabeled in some way, either misrepresenting the cannabinoids contained therein or their concentrations. 



During our conversation we discuss




What has caused the rise of semi-synthetic cannabinoids in the market? 



How Michelle got involved testing unregulated hemp and cannabis products 



Some of the adverse events that have occured from consuming semi-synthetic cannabinoids 



How the LS-MS/MS method allows Michelle’s team to see compounds other labs can’t  



How consumers can protect themselves from mislabeled products



Whether federal legalization of cannabis would eliminate the semi-synthetic market 




Thanks to This Episode's Sponsor: PRICH Biotech



PRICH Biotech, Corp. is a vertically integrated company dedicated to the cultivation, manufacture and dispensing of medicinal Cannabis in Puerto Rico. 



With over 500,000 square feet of state-of-the-art facilities, Prich uses the highest standards of agricultural and manufacturing practices to guarantee the highest standard of medicinal cannabis. Their mission is to offer a natural and unique experience through medicinal cannabis that raises the patient's well-being and quality of life.



Learn more at prichbiotech.com. 



Additional Resources




Register for CannMed 25



Meet the CannMed 25 Speakers



Review the Podcast



CannMed Archive
CannMed Coffee Talk
Brought to you by Medicinal Genomics & Advanced Nutrients